Table 1 Characteristics of HPV negative versus HPV positive patients
From: Prognostic role of HPV infection in esophageal squamous cell carcinoma
Variable | HPV negative | HPV positive | |
|---|---|---|---|
(n = 60) no. (%) | (n = 14) no. (%) | ||
Age at diagnosis | ≤ 60 | 29 (48.3%) | 4 (28.6%) |
> 60 | 31 (51.7%) | 10 (71.4%) | |
Gender | Female | 10 (16.7%) | 6 (42.9%) |
Male | 50 (83.3%) | 8 (57.1%) | |
Tumor location | Upper third | 8 (13.3%) | 4 (28.6%) |
Middle third | 35 (58.3%) | 6 (42.8%) | |
Lower third | 17 (28.4%) | 4 (28.6%) | |
Clinical T stage | cT3 | 26 (43.3%) | 8 (57.1%) |
cT4 | 34 (56.7%) | 6 (42.9%) | |
Clinical N stage | cN0 | 6 (10.0%) | 4 (28.6%) |
cN1–2 | 54 (90.0%) | 10 (71.4%) | |
Clinical M stage | cM0 | 49 (81.7%) | 14 (100.0%) |
cM1 | 11 (18.3%) | 0 (0.0%) | |